Author

R. Ferrandino

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Utility of Early Post-Treatment Circulating Tumor Tissue Modified Viral HPV DNA Testing in HPV-Associated Oropharyngeal Cancer.

BACKGROUND TTMV-HPV DNA testing is prognostic during post-treatment surveillance of HPV-associated oropharyngeal squamous cell carcinoma (OPSCC), but the significance of testing before conventional 3-month response assessment remains unclear. METHODS We retrospectively analyzed 332 patients across 8 US sites with bio...

Scott A. Roof, J. Jabalee, E. Rettig et al. · Head and Neck · 0 citations

Open access Oct 2026

Dysregulation of epithelial differentiation architecture underlies field cancerization in head and neck cancer

Head and neck squamous cell carcinoma (HNSCC) has exceptionally high recurrence rates, exceeding 50%, contributing to mortality and morbidity. This recurrence rate is proposed to be due to field cancerization, a phenomenon where tumor-adjacent “field” tissue that appears histologically normal harbors molecular changes...

Claire B. Mills, Yin Huang, Chan-Mi Lee et al. · bioRxiv · 0 citations

Open access Sep 2026

The Utility of Tumor Tissue-Modified Viral HPV DNA Testing for HPV-Associated Non-Oropharyngeal Squamous Cell Carcinoma of the Head and Neck.

BACKGROUND Tumor tissue-modified viral (TTMV) human papillomavirus (HPV) DNA testing has high diagnostic and surveillance performance in HPV-associated oropharyngeal squamous cell carcinoma, but its utility in HPV-associated non-oropharyngeal (non-OP) head and neck squamous cell carcinoma (HNSCC) is not well defined....

Peter V. Cooke, Daniel O. Kraft, Susmita Chennareddy et al. · Head and Neck · 0 citations